Alatrofloxacin: Difference between revisions
Content deleted Content added
Mike Serfas (talk | contribs) Per indirect WP:AR1 request; just a brief stub |
cat, stub sort |
||
| Line 1: | Line 1: | ||
'''Alatrofloxacin (Trovan IV)''' is a [[fluoroquinolone]] [[antibiotic]] developed by [[Pfizer]], delivered as a [[mesylate]] salt.<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5489474|title=PubChem CID 5489474}}</ref> It is the parental [[prodrug]] of [[Trovafloxacin]] (Trovan), a broad spectrum antibiotic introduced in 1998 which encountered criticism for its Nigerian trials and adverse clinical reactions.<ref>PMID 14568230</ref><ref>PMID 16735322</ref> |
'''Alatrofloxacin (Trovan IV)''' is a [[fluoroquinolone]] [[antibiotic]] developed by [[Pfizer]], delivered as a [[mesylate]] salt.<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5489474|title=PubChem CID 5489474}}</ref> It is the parental [[prodrug]] of [[Trovafloxacin]] (Trovan), a broad spectrum antibiotic introduced in 1998 which encountered criticism for its Nigerian trials and adverse clinical reactions.<ref>PMID 14568230</ref><ref>PMID 16735322</ref> |
||
==References== |
|||
<references /> |
<references /> |
||
| ⚫ | |||
[[Category:Fluoroquinolone antibiotics]] |
|||
[[Category:Prodrugs]] |
|||
| ⚫ | |||
Revision as of 23:30, 20 October 2007
Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.[1] It is the parental prodrug of Trovafloxacin (Trovan), a broad spectrum antibiotic introduced in 1998 which encountered criticism for its Nigerian trials and adverse clinical reactions.[2][3]
References
- ^ "PubChem CID 5489474".
- ^ PMID 14568230
- ^ PMID 16735322
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |